FDA Approves Pfizer ’s RSV Vaccine for Adults 60 and Older

Though agency advisers had some safety concerns, the Pfizer shot is expected to be available before the winter R.S.V. season.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Drugs (Pharmaceuticals) Vaccination and Immunization Elderly Respiratory Syncytial Virus (RSV) Guillain-Barre Syndrome Winter (Season) Pfizer Inc GSK PLC Food and Drug Administration Centers for Disease Control and Prevention Viruses Source Type: news